Autolus Therapeutics plc financial data

Symbol
AUTL on Nasdaq
Location
London, United Kingdom
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 12 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 849 % -39.5%
Quick Ratio 25.3 %
Debt-to-equity 106 % +43.5%
Return On Equity -63.8 % -0.17%
Return On Assets -30.9 % +15.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 266M shares +0.01%
Entity Public Float 614M USD +120%
Weighted Average Number of Shares Outstanding, Basic 266M shares +0.02%
Weighted Average Number of Shares Outstanding, Diluted 266M shares +0.02%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 8.98M USD -11%
Revenue from Contract with Customer, Excluding Assessed Tax 21.2M USD
Research and Development Expense 113M USD -22.2%
General and Administrative Expense 83.1M USD +116%
Operating Income (Loss) -274M USD -25.2%
Nonoperating Income (Expense) 53.8M USD +50.9%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -220M USD +18.5%
Income Tax Expense (Benefit) 4.62M USD +11161%
Net Income (Loss) Attributable to Parent -225M USD +16.8%
Earnings Per Share, Basic 0 USD/shares +32%
Earnings Per Share, Diluted 0 USD/shares +32%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 86.1M USD -86.9%
Accounts Receivable, after Allowance for Credit Loss, Current 15K USD -86.2%
Inventory, Net 27.7M USD
Other Assets, Current 0 USD
Assets, Current 515M USD -28.3%
Deferred Income Tax Assets, Net 2.39M USD -29.5%
Property, Plant and Equipment, Net 66.9M USD +51%
Operating Lease, Right-of-Use Asset 56.6M USD -6.41%
Assets 662M USD -20%
Accounts Payable, Current 11M USD +673%
Employee-related Liabilities, Current 22.6M USD +46.4%
Accrued Liabilities, Current 52.3M USD +10.1%
Contract with Customer, Liability, Current 4.8M USD
Liabilities, Current 83.1M USD +58.3%
Contract with Customer, Liability, Noncurrent 253M USD +10.9%
Operating Lease, Liability, Noncurrent 61M USD +25.4%
Other Liabilities, Noncurrent 472K USD +5.59%
Liabilities 396M USD +13.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax -4.92M USD -448%
Retained Earnings (Accumulated Deficit) -1.3B USD -21%
Stockholders' Equity Attributable to Parent 265M USD -44.3%
Liabilities and Equity 662M USD -20%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -75.6M USD -86.5%
Net Cash Provided by (Used in) Financing Activities 0 USD -100%
Net Cash Provided by (Used in) Investing Activities -59.5M USD -11072%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -132M USD -125%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 87.6M USD -86.7%
Deferred Tax Assets, Valuation Allowance 157M USD +27.7%
Deferred Tax Assets, Gross 160M USD +27.2%
Operating Lease, Liability 65.8M USD +26.1%
Depreciation 8.2M USD +10.8%
Payments to Acquire Property, Plant, and Equipment 8.24M USD +1447%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -229M USD +3.58%
Lessee, Operating Lease, Liability, to be Paid 119M USD +8.4%
Operating Lease, Liability, Current 4.83M USD +35.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 8.96M USD +5.25%
Lessee, Operating Lease, Liability, to be Paid, Year One 6.85M USD
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 52.9M USD -7.69%
Lessee, Operating Lease, Liability, to be Paid, Year Three 8.19M USD -8.07%
Deferred Tax Assets, Operating Loss Carryforwards 136M USD +30.5%
Lessee, Operating Lease, Liability, to be Paid, Year Four 6.16M USD -24.5%
Operating Lease, Payments 1.73M USD +33.1%
Additional Paid in Capital 1.57B USD +1.12%
Amortization of Intangible Assets 1.25M USD
Depreciation, Depletion and Amortization 1.99M USD +10.3%
Share-based Payment Arrangement, Expense 17.2M USD +37.9%
Interest Expense -17M USD -124%